• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

科威特血糖控制良好和未控制的糖尿病患者中尿路感染的患病率及抗菌药物敏感性

Prevalence of Urinary Tract Infection and Antimicrobial Susceptibility among Diabetic Patients with Controlled and Uncontrolled Glycemia in Kuwait.

作者信息

Sewify May, Nair Shinu, Warsame Samia, Murad Mohamed, Alhubail Asma, Behbehani Kazem, Al-Refaei Faisal, Tiss Ali

机构信息

Clinical Services Department, Dasman Diabetes Institute, P.O. Box 1180, 15462 Kuwait, Kuwait.

Biochemistry & Molecular Biology Unit, Dasman Diabetes Institute, P.O. Box 1180, 15462 Kuwait, Kuwait.

出版信息

J Diabetes Res. 2016;2016:6573215. doi: 10.1155/2016/6573215. Epub 2015 Dec 30.

DOI:10.1155/2016/6573215
PMID:26844231
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4710901/
Abstract

Diabetic patients have higher risk of urinary tract infection (UTI). In the present study, we investigated the impact of glycemic control in diabetic patients on UTI prevalence, type of strains, and their antimicrobial drugs susceptibility. This study was conducted on urine samples from 722 adult diabetic patients from which 252 (35%) samples were positive for uropathogens. Most UTI cases occurred in the uncontrolled glycemic group (197 patients) versus 55 patients with controlled glycemia. Higher glycemic levels were measured in uncontrolled glycemia group (HbA1c = 8.3 ± 1.5 and 5.4 ± 0.4, resp., P < 0.0001). Females showed much higher prevalence of UTI than males in both glycemic groups (88.5% and 11.5%, resp., P < 0.0001). In the uncontrolled glycemia group 90.9% of the UTI cases happened at ages above 40 years and a clear correlation was obtained between patient age ranges and number of UTI cases (r = 0.94; P = 0.017), whereas in the group with controlled glycemia no trend was observed. Escherichia coli was the predominant uropathogen followed by Klebsiella pneumoniae and they were together involved in 76.2% of UTI cases. Those species were similarly present in both diabetic groups and displayed comparable antibiotic resistance pattern. These results highlight the importance of controlling glycemia in diabetic patients to reduce the UTI regardless of age and gender.

摘要

糖尿病患者发生尿路感染(UTI)的风险更高。在本研究中,我们调查了糖尿病患者血糖控制对UTI患病率、菌株类型及其对抗菌药物敏感性的影响。本研究对722例成年糖尿病患者的尿液样本进行了检测,其中252例(35%)样本的尿路病原体呈阳性。大多数UTI病例发生在血糖控制不佳组(197例患者),而血糖控制良好组有55例患者。血糖控制不佳组的血糖水平更高(糖化血红蛋白分别为8.3±1.5和5.4±0.4,P<0.0001)。在两个血糖组中,女性UTI的患病率均明显高于男性(分别为88.5%和11.5%,P<0.0001)。在血糖控制不佳组中,90.9%的UTI病例发生在40岁以上,患者年龄范围与UTI病例数之间存在明显的相关性(r=0.94;P=0.017),而在血糖控制良好组中未观察到这种趋势。大肠杆菌是主要的尿路病原体,其次是肺炎克雷伯菌,它们共同导致了76.2%的UTI病例。这些菌种在两个糖尿病组中均有类似分布,且显示出相似的抗生素耐药模式。这些结果凸显了控制糖尿病患者血糖以降低UTI的重要性,无论年龄和性别如何。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0984/4710901/eaf7e123fad1/JDR2016-6573215.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0984/4710901/1baae5859791/JDR2016-6573215.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0984/4710901/2aa6685dd09c/JDR2016-6573215.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0984/4710901/eaf7e123fad1/JDR2016-6573215.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0984/4710901/1baae5859791/JDR2016-6573215.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0984/4710901/2aa6685dd09c/JDR2016-6573215.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0984/4710901/eaf7e123fad1/JDR2016-6573215.003.jpg

相似文献

1
Prevalence of Urinary Tract Infection and Antimicrobial Susceptibility among Diabetic Patients with Controlled and Uncontrolled Glycemia in Kuwait.科威特血糖控制良好和未控制的糖尿病患者中尿路感染的患病率及抗菌药物敏感性
J Diabetes Res. 2016;2016:6573215. doi: 10.1155/2016/6573215. Epub 2015 Dec 30.
2
Asymptomatic bacteriuria and symptomatic urinary tract infections (UTI) in patients with diabetes mellitus in Tikur Anbessa Specialized University Hospital, Addis Ababa, Ethiopia.埃塞俄比亚亚的斯亚贝巴提库尔安贝萨专科医院糖尿病患者的无症状菌尿和有症状的尿路感染
Ethiop Med J. 2012 Jul;50(3):239-49.
3
Effect of Diabetes Mellitus on the Spectrum of Uropathogens and the Antimicrobial Resistance in Patients with Urinary Tract Infection.糖尿病对尿路感染患者尿病原菌谱及抗菌药物耐药性的影响。
Arch Razi Inst. 2024 Feb 1;79(1):92-101. doi: 10.32592/ARI.2024.79.1.92. eCollection 2024 Feb.
4
Urinary tract infections and antimicrobial sensitivity among diabetic patients at Khartoum, Sudan.苏丹喀土穆糖尿病患者的尿路感染及抗菌药物敏感性
Ann Clin Microbiol Antimicrob. 2015 Apr 21;14:26. doi: 10.1186/s12941-015-0082-4.
5
Bacterial Quality of Urinary Tract Infections in Diabetic and Non Diabetics of the Population of Ma'an Province, Jordan.约旦马安省糖尿病患者和非糖尿病患者尿路感染的细菌学特征
Pak J Biol Sci. 2017;20(4):179-188. doi: 10.3923/pjbs.2017.179.188.
6
Common uropathogens and their antibiotic susceptibility pattern among diabetic patients.糖尿病患者常见尿路病原体及其抗生素敏感性模式。
BMC Infect Dis. 2019 Jan 10;19(1):43. doi: 10.1186/s12879-018-3669-5.
7
Prevalence and antibiotic susceptibility of Uropathogens from cases of urinary tract infections (UTI) in Shashemene referral hospital, Ethiopia.埃塞俄比亚沙斯梅尼转诊医院尿路感染(UTI)病例的尿路病原体流行情况和抗生素药敏性。
BMC Infect Dis. 2018 Jan 10;18(1):30. doi: 10.1186/s12879-017-2911-x.
8
Urinary tract infections in patients with diabetes mellitus.糖尿病患者的尿路感染
J Infect. 1992 Mar;24(2):169-74. doi: 10.1016/0163-4453(92)92876-k.
9
Urinary Tract Infections in Kidney Transplant Patients Due to Escherichia coli and Klebsiella pneumoniae-Producing Extended-Spectrum β-Lactamases: Risk Factors and Molecular Epidemiology.肾移植患者中由产超广谱β-内酰胺酶的大肠埃希菌和肺炎克雷伯菌引起的尿路感染:危险因素与分子流行病学
PLoS One. 2015 Aug 3;10(8):e0134737. doi: 10.1371/journal.pone.0134737. eCollection 2015.
10
Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.医疗保健相关尿路感染中产超广谱β-内酰胺酶大肠埃希菌和肺炎克雷伯菌的抗菌药敏性:聚焦对磷霉素的敏感性
Int Urol Nephrol. 2015 Jul;47(7):1059-66. doi: 10.1007/s11255-015-1018-9. Epub 2015 May 31.

引用本文的文献

1
Antimicrobial resistance of uropathogens in diabetic patients.糖尿病患者尿路病原体的抗菌药物耐药性
BMC Infect Dis. 2025 Jul 26;25(1):945. doi: 10.1186/s12879-025-11358-8.
2
Establishment and validation of a risk prediction model for urinary tract infection in elderly patients with type 2 diabetes mellitus.2型糖尿病老年患者尿路感染风险预测模型的建立与验证
Front Endocrinol (Lausanne). 2025 Jul 23;16:1557185. doi: 10.3389/fendo.2025.1557185. eCollection 2025.
3
Prevalence and Predictors of Urinary Tract Infections Among Patients With Type 2 Diabetes Attending Primary Health Care Centers in Buraidah City, Saudi Arabia.

本文引用的文献

1
Lower urinary tract symptoms in women with diabetes mellitus: a current review.糖尿病女性的下尿路症状:当前综述
Curr Urol Rep. 2014 Oct;15(10):440. doi: 10.1007/s11934-014-0440-3.
2
Urinary tract infection and antibiotic sensitivity pattern among diabetics.糖尿病患者的尿路感染及抗生素敏感性模式
Nepal Med Coll J. 2013 Mar;15(1):1-4.
3
Clinical profile of urinary tract infections in diabetics and non-diabetics.糖尿病患者与非糖尿病患者尿路感染的临床特征。
沙特阿拉伯布赖代市初级卫生保健中心2型糖尿病患者尿路感染的患病率及预测因素
Cureus. 2025 Jun 24;17(6):e86652. doi: 10.7759/cureus.86652. eCollection 2025 Jun.
4
Prevalence, bacterial profile, antimicrobial susceptibility patterns and associated risk factors of bacterial UTI among diabetic patients at Jigjiga University Sheik Hasan Yabare Comprehensive Specialized Hospital, Jigjiga, Eastern Ethiopia.埃塞俄比亚东部吉吉加市吉吉加大学谢赫·哈桑·亚巴雷综合专科医院糖尿病患者细菌性尿路感染的患病率、细菌谱、抗菌药物敏感性模式及相关危险因素
BMC Infect Dis. 2025 May 31;25(1):777. doi: 10.1186/s12879-025-11122-y.
5
Deciphering the Complex Relationships Between Potential Renal Acid Load, Carbohydrate Intake, and Urine pH in Postmenopausal Women With Recurrent Urinary Tract Infections.解读复发性尿路感染绝经后女性潜在肾酸负荷、碳水化合物摄入量与尿液pH值之间的复杂关系
Am J Lifestyle Med. 2025 May 22:15598276251344486. doi: 10.1177/15598276251344486.
6
Characterization of the Phenotypic and Genotypic Antibiotic Resistance Markers in () Associated With Diabetes and Nondiabetic Patients.与糖尿病患者和非糖尿病患者相关的()中表型和基因型抗生素耐药标志物的特征分析 。 注:原文括号处内容缺失,翻译可能不太完整准确。
Int J Microbiol. 2025 Jan 31;2025:3694023. doi: 10.1155/ijm/3694023. eCollection 2025.
7
Tolerability of Sodium-Glucose Co-transporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Retrospective Cohort Study.2型糖尿病患者中钠-葡萄糖协同转运蛋白2抑制剂的耐受性:一项回顾性队列研究
Cureus. 2024 Dec 16;16(12):e75798. doi: 10.7759/cureus.75798. eCollection 2024 Dec.
8
Prevalence of Antimicrobial Resistance Among the WHO's AWaRe Classified Antibiotics Used to Treat Urinary Tract Infections in Diabetic Women.用于治疗糖尿病女性尿路感染的世界卫生组织(WHO)按AWaRe分类的抗生素中的耐药性流行情况。
Antibiotics (Basel). 2024 Dec 14;13(12):1218. doi: 10.3390/antibiotics13121218.
9
Risk factors for urinary tract infection in elderly patients with type 2 diabetes: A protocol for systematic review and meta-analysis.老年 2 型糖尿病患者尿路感染的危险因素:系统评价和荟萃分析方案。
PLoS One. 2024 Sep 26;19(9):e0310903. doi: 10.1371/journal.pone.0310903. eCollection 2024.
10
Effect of Diabetes Mellitus on the Spectrum of Uropathogens and the Antimicrobial Resistance in Patients with Urinary Tract Infection.糖尿病对尿路感染患者尿病原菌谱及抗菌药物耐药性的影响。
Arch Razi Inst. 2024 Feb 1;79(1):92-101. doi: 10.32592/ARI.2024.79.1.92. eCollection 2024 Feb.
Australas Med J. 2014 Jan 31;7(1):29-34. doi: 10.4066/AMJ.2014.1906. eCollection 2014.
4
Urinary tract infections in special populations: diabetes, renal transplant, HIV infection, and spinal cord injury.特殊人群中的尿路感染:糖尿病、肾移植、HIV 感染和脊髓损伤。
Infect Dis Clin North Am. 2014 Mar;28(1):91-104. doi: 10.1016/j.idc.2013.09.006. Epub 2013 Dec 8.
5
Impact of extended-spectrum β-lactamase-producing organisms on clinical and economic outcomes in patients with urinary tract infection.产超广谱β-内酰胺酶微生物对尿路感染患者临床及经济结局的影响。
J Hosp Med. 2014 Apr;9(4):232-8. doi: 10.1002/jhm.2157. Epub 2014 Jan 24.
6
Direct medical costs of complications of diabetes in the United States: estimates for event-year and annual state costs (USD 2012).美国糖尿病并发症的直接医疗费用:按事件年度和年度州别估算的费用(2012 年美元)。
J Med Econ. 2014 Mar;17(3):176-83. doi: 10.3111/13696998.2014.882843. Epub 2014 Jan 28.
7
Urinary tract infection in diabetes: epidemiologic considerations.糖尿病患者的尿路感染:流行病学考虑。
Curr Infect Dis Rep. 2014 Jan;16(1):389. doi: 10.1007/s11908-013-0389-2.
8
Urinary tract infection in randomized phase III studies of canagliflozin, a sodium glucose co-transporter 2 inhibitor.在钠-葡萄糖协同转运蛋白 2 抑制剂卡格列净的随机 III 期研究中尿路感染。
Postgrad Med. 2014 Jan;126(1):7-17. doi: 10.3810/pgm.2014.01.2720.
9
Urinary tract infections in patients with diabetes treated with dapagliflozin.达格列净治疗糖尿病患者的尿路感染。
J Diabetes Complications. 2013 Sep-Oct;27(5):473-8. doi: 10.1016/j.jdiacomp.2013.05.004. Epub 2013 Jul 10.
10
Vulvovaginitis and balanitis in patients with diabetes treated with dapagliflozin.达格列净治疗的糖尿病患者的外阴阴道炎和阴茎头炎。
J Diabetes Complications. 2013 Sep-Oct;27(5):479-84. doi: 10.1016/j.jdiacomp.2013.04.012. Epub 2013 Jun 24.